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0022-2836/© 2009 Elsevier Ltd. Open accThe crystal structures of a biologically and therapeutically active recombi-
nant homotrimeric fragment of human lung surfactant protein D with a
series of bound ligands have been determined. While the structures reveal
various different binding modes, all utilise a similarly positioned pair of
mannose-type O3′ and O4′ hydroxyls with no direct interaction between
any non-terminal sugar and protein. The orientation, position, and
interactions of the bound terminal sugar depend on the sugar itself, the
presence and form of glycosidic linkage, and the environment in the crystal,
which, via Asp325, places stereochemical and electronic constraints,
different for the three different subunits in the homotrimer, on the ligand-
binding site. As a direct consequence of this influence, the other binding-
pocket flanking residue, Arg343, exhibits variable conformation and
variable interactions with bound ligand and leaves open to question
which orientation of terminal mannobiose, and of other terminal disacchar-
ides, may be present in extended physiological ligands. The combined
structural evidence shows that there is significant flexibility in recognition;
that Asp325, in addition to Arg343, is an important determinant of ligand
selectivity, recognition, and binding; and that differences in crystal contact
interfaces exert, through Asp325, significant influence on preferred binding
modes.
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Human lung surfactant proteinD (hSP-D) exerts its
biological role through recognition of an array of
carbohydrate present in the surface lipopolysacchar-
ides and phospholipids,1,2 peptidoglycans and
glycosaminoglycans3,4 of a wide range of microbial
targets, such as viruses, bacteria, yeasts, and fungi.5–7
Interaction of hSP-D with these pathogens promotes
microbial aggregation and enhanced uptake and
killing by neutrophils and alveolar macrophages.7
Recent binding studies have also suggested a role for
SP-D in the recognition and clearance of foreign and
host nucleic acids, and apoptotic cells, in the lung,
thus down-regulating inflammation and minimising
autoantibody generation.8–10 Although predomi-
nantly characterised in the lung, hSP-D has also
been shown to be expressed at various mucosal
Fig. 1. C-terminal sequences of selected collectins (hSP-D numbering). Known neck/CRD structures are underlined,
and reported ligand-bound structures are highlighted. Residues that bind to both calcium and (except SP-A 323 and 342)
ligand are underlined, and those that flank the ligand-binding site (SP-D 325 and 343) are highlighted.
777Ligand-Binding Determinants in hSP-Dsites.11 Structurally,12 SP-D adopts a tetrameric
cruciform-like structure, with four arms of equal
length. Ligand recognition occurs in carbohydrate
recognition domains (CRDs), which are spatially
separated, in a trimeric configuration, at the end of
triple-helical collagenous stalks linked to the CRDs
through short α-helical coiled-coil neck domains.
Pulmonary SP-D specifically binds to phosphati-
dylinositol (PI),2 which accounts for 3% (w/w) of
surfactant. While previous reports are unclear as to
whether this binding involves the neck, the CRD, or
both,1,2,13 inositol phosphate and myo-inositol have
recently been shown to bind to the principal CRD
calcium ion, suggesting that the CRD mediates PI
recognition.14 The interaction of SP-D with phos-
pholipids influences surfactant homeostasis and
alveolar cell morphology, with SP-D-deficient mice
exhibiting an accumulation of lung surfactant lipids
and abnormalities in the morphology of alveolar
type II cells and macrophages.15 It has been
suggested16 that PI binding may inhibit interaction
of SP-D with microorganisms in vivo, although SP-
D-induced microbial aggregation in the airways,
which contributes in vivo to host defence, does not
appear to be affected by this interaction.
Current structural knowledge indicates that path-
ogen recognition in the lungs is mediated by CRD
Ca-dependent binding of terminal monosaccharide
residues14,17–19 characteristic of bacterial and fungal
cell surfaces, although modelling studies predict
that binding can also occur through internal (non-
terminal) residues in glucosyl trisaccharides.20 Re-
cent structural studies of glucosyl trisaccharides
have demonstrated that, in addition to terminal
sugar glc1 binding by the principal CRD calcium
ion, a phenylalanine residue proximal to the
carbohydrate-binding groove interacts directly
with glc3 and is critical for simple maltoside and
maltotriose binding.18 It has been suggested that the
fairly nonspecific monosaccharide binding and the
geometrical relationship between the multiple CRDs
may explain the ability of the collectins to recognise
and bind to the surface patterns of carbohydrate
presented by pathogenic microorganisms and thus
discriminate between self and non-self.21
The Ca-dependent carbohydrate-binding pocket
in the collectins is highly conserved in terms of the
residues that coordinate to both the calcium ion andthe ligand through a pair of hydroxyls positioned in
a manner similar to the mannose-type O3′ and O4′
equatorial pair (see Fig. 1). The SP-A residue that
replaces Asn323 (hSP-D numbering) is oriented such
that the main-chain carbonyl is placed in the
position of Asn323 OD1 in other collectins.22 The
roles of both Arg34314,17,23,24 and Asp32517,25 in SP-
D ligand selectivity and specificity have been
investigated by structural, modelling, and mutagen-
esis studies. Elegant work by Weiss et al. on ligand-
bound structures of rat MBP26–28 suggests that the
highly variable residue equivalent to hSP-D 325 on
one side of the binding site is a major determinant of
bound ligand orientation in MBP. Insertion of the
CL-43 Arg-Ala-Lys (RAK) motif to immediately
precede Asp325 in hSP-D results in enhanced
interactions with influenza A virus and saccharide-
binding characteristics that more closely resemble
CL-43.29 On the opposite side of the binding site, the
residue equivalent to Arg343 is conserved as Arg or
Lys in all known SP-D sequences, and its role in PI
recognition and binding,14 in discrimination be-
tween glucose and GlcNAc,23 in recognition of
multivalent microbial ligands,24 and in the selection,
recognition, and binding of physiological ligands in
general17 has been highlighted. There is, however,
no clear explanation of the structurally characterised
variability of orientation or of the relative affinity for
the variety of ligands recognised by the collectins.
A recombinant homotrimeric form of truncated
hSP-D (rfhSP-D) expressed in Escherichia coli, com-
posed of the neck region plus three CRDs, has been
shown to have therapeutic effects in murine models
of pulmonary hypersensitivity and infection in-
duced by an opportunistic fungus, Aspergillus
fumigatus.30–32 Although rfhSP-D constitutes only a
relatively small fragment (60 kDa) of the entire
natural hSP-D molecule (540 kDa), it appears to
retain significant biological activity both in vitro and
in vivo.32–35 The structure of rfhSP-D has been
reported to 2.3 Å36 as well as high-resolution
structures of rfhSP-D (1.4 Å) and maltose-bound
rfhSP-D (1.6 Å).17 More recent structural work on a
recombinant neck+CRD hSP-D trimer has included
complexes with maltotriose, p-nitrophenyl malto-
side, myo-inositol, inositol-1-phosphate, heptoses, α-
Me-man, and α1-2 mannobiose1.4,18,19,24 Inositol-1-
phosphate binds via O4′ andO5′ in a similar manner
Fig. 2. Themanα1–2man-bound
rfhSP-D trimer showing the bound
manα1–2man (only the terminal
mannose man1 is visible in the
electron density) and the calcium
ions (green spheres). (a) Viewed
down the molecular 3-fold axis. (b)
Viewed perpendicular to the mo-
lecular 3-fold axis.
778 Ligand-Binding Determinants in hSP-Dto the standard mannose-type binding through the
adjacent equatorial hydroxyls O3′ and O4′,14 and L,
D-heptose has been shown to bind preferentially
through the O6′ and O7′ hydroxyls of the glycerol
side chain rather than through the standard O3′ and
O4′ of the pyranose ring.19 In both cases, the
coordinated hydroxyls are positioned and bound in
a manner almost identical with the mannose-type
equatorial hydroxyl pair O3′ and O4′, which bind
in the remainder of the array of structurally
characterised hSP-D–ligand complexes.14,17–19,24
Recent binding studies based on competition with
the SP-D–mannan interaction on BIAcore chip havesuggested novel ligands for hSP-D. These ligands
include bacterial and host-genome nucleic acids and
their components such as D-ribose and (deoxy)
ribonucleotide triphosphates,9,10 peptidoglycan
components such as N-acetyl muramic acid,3 and
the glycosaminoglycans of proteoglycans such as
the GalNAc-4-sulfate contained in the dermatan
sulfate component of decorin.4 Due to our failure to
introduce these ligands into rfhSP-D crystals, either
by soaking or co-crystallisation, and to further
investigate the binding of mono- and disaccharides,
we have undertaken an in-depth structural analysis
of a series of rfhSP-D–ligand complexes including
Fig. 3. The coordination of the calcium ion Ca1 and the bound ligands in selected subunits of the rfhSP-D–ligand
complexes. (a) Chain B of the inositol phosphate structure. (b) Chain A, maltose. (c) Chain A, galactose. (d) Chain A,
manα1–2man. (e) Chain B, manα1–4man. (f) Chain A, manα1–4man.
779Ligand-Binding Determinants in hSP-Dmanα1–2man (characteristic of the branch repeating
unit of mannan), manα1–4man (providing a direct
comparison with manα1–2man and with maltose,17
the favoured ligand of hSP-D), and galactose. For
consistency of interpretation, we have redetermined
the structure of the physiologically important
inositol 1-monophosphate (IP) complex14 to higher
resolution for a more complete data set [99%
complete to 1.75 Å here; 92% complete to 1.89 Å in
Protein Data Bank (PDB) file 2ork14].Results
Overall structures
The overall structures of rfhSP-D reveal the
trimeric aggregate with three spatially separated C-
terminal globular CRD domains (residues 236–355)
and an extended α-helical coiled-coil neck region
(residues 203–235) (Fig. 2). The first few residues of
Fig. 4. The influence of the variable crystal contacts on the orientation and interactions of bound mannobiose and
Arg343. (a–c) manα1–2man chains A, B, and C, respectively. (d–f) manα1–4man chains A, B, and C, respectively. In all
figures, the symmetry contact protein molecule and the bound terminal mannose are represented in grey, with selected
residues of the hSP-D monomer represented by yellow main-chain bonds and white side-chain bonds. Coordination (to
Ca1 and ligand) distances are given in Table 1 with symmetry contact distances in Table 2. The crystal contacts with
chains B and C, in both structures, are very similar but not identical. Of the six subunit structures, the only pairs with
similar ligand orientation and similar ligand non-bonded contacts are chains B and C in manα1–4man and chain A in both
manα1–2man andmanα1–4man, although in the latter case, the two orientations of the Arg343 side chain are significantly
different.
780 Ligand-Binding Determinants in hSP-D
Fig. 5. Stereo view of the electron density in the chain A calcium and ligand-binding site of the α1-4 mannobiose-
bound structure. The difference electron density map (Fo−Fc) is calculated from the observed data (Fo) and the model
(Fc) prior to adding ligand into the model but after location and refinement of water molecules (none of which moved
into the ligand-binding site on refinement). The map, calculated at 1.65 Å resolution, is solvent flattened and contoured at
2.5 r.m.s.d.
781Ligand-Binding Determinants in hSP-Dthe neck region and the 24-residue N-terminal
collagen tail are not visible in the electron density
map. While the structures reveal various different
ligand-binding modes, all utilise a similarly posi-
tioned pair of mannose-type O3′ and O4′ hydroxyls
(Figs. 3–5 and Table 1) with no direct interaction
between any non-terminal sugar and protein. The
calcium ions reported in the rfhSP-D structure, three
per CRD plus Ca4, located on the trimeric axis in a
pore at the bottom of the funnel formed by the three
CRDs and close to the neck–CRD interface,17 are
present in all the ligand-bound structures presented
here. Within the molecular trimer, the calcium ionTable 1. Calcium and ligand binding
Chain A
Atom 1 Atom 2 gal m12m IP m14m ga
Ca1 Glu321 OE1 2.69 2.41 2.57 2.63 2.6
Asn323 OD1 2.62 2.57 2.48 2.50 2.5
Glu329 OE1 2.52 2.34 2.49 2.44 2.5
Asn341 OD1 2.55 2.51 2.38 2.40 2.4
Asp342 OD1 2.48 2.31 2.28 2.33 2.4
Asp342 O 2.66 2.66 2.62 2.63 2.6
Ligand Oa 2.60 2.78 2.59 2.52 2.5
Ob 2.66 2.58 2.49 2.55 2.6
Ligand W 2.59
W 2.49
O1′ 2.66 2.6
O2′ 2.60 2.5
O3′ 2.78 2.52
O4′ 2.58 2.55
O5′
Oa Glu321 OE2 2.67 2.49 2.69 2.58 2.5
Asn323 ND2 2.73 2.86 2.65 2.67 2.8
Ob Glu329 OE2 2.69 2.52 2.62 2.63 2.5
Asn341 ND2 2.98 3.20 3.02 2.95 3.0
The galactose-bound structure is indicated by gal, the α1-2 mannobios
by m14m. As shown in subsequent rows of the table, Oa and Ob repres
α1-2 mannobiose and for chain A of the α1-4 mannobiose structure, O4
and O5′ in chains B and C of the inositol phosphate structure, and w
distances are given in angstroms.Ca4 is coordinated by all three Glu232, each of which
also interacts with Lys246 in the same chain. These
exposed lysines form a positively charged surface
around the trimeric axis at the bottom of the central
pore. In the galactose-bound structures, there is
evidence of a minor conformation of Glu232 in chain
B, which allows the side chain (OE1) to interact with
the asymmetric tyrosine Tyr228 in chain C rather
than Lys246 in chain B.
In this crystal form, the ligand-binding site
flanking residue Asp325 in all three chains forms a
crystal contact to other trimers, with a broad contact
region covering residues 322–326 (see Table 2 andChain B Chain C
l m12m IP m14m gal m12m IP m14m
2 2.62 2.55 2.50 2.58 2.62 2.56 2.49
2 2.38 2.42 2.38 2.54 2.47 2.41 2.40
7 2.40 2.49 2.46 2.53 2.31 2.36 2.46
8 2.47 2.34 2.38 2.49 2.57 2.38 2.38
6 2.22 2.24 2.30 2.46 2.29 2.25 2.29
4 2.63 2.58 2.57 2.67 2.66 2.59 2.61
9 2.44 2.58 2.56 2.54 2.47 2.57 2.53
1 2.86 2.54 2.58 2.67 2.55 2.55 2.66
1 2.67
9 2.54
2.44 2.58 2.47 2.66
2.86 2.58 2.56 2.55 2.57 2.53
2.54 2.55
5 2.56 2.56 2.61 2.60 2.40 2.58 2.62
6 2.84 2.91 2.86 2.96 3.01 2.84 2.94
6 2.51 2.59 2.45 2.58 2.42 2.62 2.55
0 3.12 2.96 3.07 3.05 3.29 3.02 3.02
e by m12m, the inositol phosphate by IP, and the α1-4 mannobiose
ent O2′ and O1′ in the galactose-bound structure, O3′ and O4′ for
′ and O3′ in chains B and C of the α1-4 mannobiose structure, O4′
ater molecules in chain A of the inositol phosphate structure. All
Table 2. Protein–protein symmetry contacts in the vicinity of the ligand-binding site and protein–ligand interactions
involving Arg343 and Asp325
Molecule 1 Chain
Symmetry
molecule 2 Chain nat malt gal IP m12m m14m
Asp325 OD1 A Tyr314 OH B 2.63 2.75 2.77 2.58 2.66 2.61
Asp325 OD1 B Lys230 NZ C 2.85 2.85 2.77 2.79 2.99 2.80
Asp325 OD1 C Lys230 NZ A 3.00 3.03 2.89 3.14 3.24 2.85
Gly326 N A Asn316 OD1 B 2.97 2.84 2.85 2.84 2.91 2.82
Asn323 O A Lys339 NZ B 2.80 2.79 2.80 2.73 2.95 2.68
Asp324 O A Lys339 NZ B 3.09 2.96 2.99 2.91 3.30 2.97
Asn323 ND2 B Ser226 OG C 2.85 2.88 2.90 2.80 3.20 2.87
Asn323 ND2 C Ser226 OG A 3.02 3.09 3.10 3.06 3.13 2.95
Pro322 O C Gln222 NE2 A 3.08 2.99 2.83 2.82 3.10 2.99
Pro322 O B Gln222 NE2 C 2.99 2.98 2.99 2.99 2.98 3.01
Protein Chain Ligand Sugar nat malt gal IP m12m m14m
Arg343 NH2 A Maltose O6′ glc1 3.06
NH1 B O2′ 3.5
NH2 C O6′ 3.34
NH1 A Galactose O6′ gal 3.13
NH1 A O5′ 3.24
NH2 A O5′ 3.19
NH1 B Galactose O6′ gal 2.97
NH1 B O5′ 3.10
NH2 B O5′ 3.08
NH1 C Galactose O6′ gal 2.92
NH1 C O5′ 2.98
NH2 C O5′ 3.06
NE B IP O6′ I 2.93
NE C O6′ 3.20
NH1 A m12m O6′ man1 2.87
NH2 A m14m O6′ man1 3.34
NH1 B m14m O2′ man1 3.20
NH1 C m14m O2′ man1 3.29
Asp325 OD2 B m12m O6′ man1 2.85
OD2 B m14m O1′ man1 3.39
OD2 C m14m O1′ man1 3.22
The unliganded and maltose-bound structures are indicated by nat and malt, respectively,17 galactose by gal, inositol phosphate by IP,
manα1–2man by m12m, and manα1–4man by m14m. Glc1 and man1 represent the terminal sugar of the bound disaccharides maltose
and mannobiose, respectively. The three chains in the rfhSP-D trimer are shown by A, B, and C. All distances are given in angstroms.
782 Ligand-Binding Determinants in hSP-DFig. 4). In chains B and C, the crystal contact
interfaces are very similar, but not identical, and
include a charge–charge interaction between
Asp325 OD1 and Lys230 NZ in a neighbouring
trimer, with, over the four structures, distances of
2.77–2.99 Å for chain B and 2.85–3.24 Å for chain C.
The only other significant specific contacts in this
region for chains B and C are hydrogen bonds
between the main-chain O of Pro322 and Gln222
NE2 (2.97–3.01 Å for chain B and 2.83–3.11 Å for
chain C) and between Asn323 ND2 and Ser226 OG
in the neighbouring molecule (averaging 2.93 Å for
chain B and 3.07 Å for chain C). The contact to
Asn323 ND2, which coordinates directly to ligand,
rotates the side chain, moving ND2 towards the
contacting serine and away from the ligand-binding
pocket as compared to chain A, resulting in a small
but significant shift in the orientation of the bound
ligand (Fig. 4).
In chain A, the 322–326 crystal contact interface,
which is entirely different to that in chains B and C
(see Table 2 and Fig. 4), results in the chain A ligand-
binding site being more restricted than those in the
other two chains. The Asp325 crystal contact is in theform of a hydrogen bond of 2.58–2.77 Å between
Asp325 OD1 and Tyr314 OH in chain B of a
neighbouring trimer, and the orientation of the
side chain of Asp325 in chain A is significantly
different to that in chains B and C. Other significant
crystal contacts at this interface include the main-
chain carbonyls of Asp324, whose side chain
coordinates to Ca2,17 the ligand-binding Asn323
interacting with Lys339 NZ in the neighbouring
molecule (2.91–3.30 Å and 2.68–2.95 Å, respectively),
and the main-chain N of Gly326 interacting with
Asn316 OD1 (2.82–2.91 Å).
The crystal contacts through Asp325 affect the
position and orientation of bound ligand, which, in
turn, influences the side chain of Arg343 that flanks
the binding pocket on the opposite side to Asp325.
The orientation of the side chain of Arg343 varies
both within and across the various ligand-bound
structures (as was reported for the maltose-bound
structure),17 particularly within the manα1–2man
and manα1–4man structures (Figs. 3 and 4). The
interactions between the ligand and Arg343 also
vary within and across the four structures, but in all
cases, they involve only the terminal sugar. The
783Ligand-Binding Determinants in hSP-Dintrachain interaction between Arg343 and Glu333
OE2 reported for the maltose-bound structure is also
present in the structures reported here, but both the
strength and the nature of the interaction vary with
the orientation of Arg343.
Mannobiose binding
While both manα1–2man and manα1–4man coor-
dinate to the CRD calcium ion Ca1 via O3′ andO4′ of
the “terminal” sugar man1, the orientation of the
terminal sugar varies and the second mannose in the
ligand is not visible in any of the CRDs (Fig. 5). The
water-mediated crystal contact, which results in the
orientation of the second sugar being defined in
chain A of the maltose-bound structure,17 is not
present in either of themannobiose structures, which
have the same space group with closely similar unit
cell parameters. In the manα1–2man complex, the
terminal mannose man1 displays the standard
orientation in all three CRDs, with the O3′ atom of
man1 interacting with Glu321 OE2 and with ND2 of
Asn323 and the O4′ atom interacting with OE2 of
Glu329 and with ND2 of Asn341 (see Figs. 3–5 and
Table 1). In chain A, there is an additional 2.87 Å
interaction of O6′ with NH1 of Arg343, while in
chain B, Arg343 is oriented differently and O6′,
though poorly defined in the electron density, is
rotated to interact with OD2 of Asp325 (2.85 Å),
which lies on the opposite side of the ligand-binding
pocket to Arg343. In the remaining subunit (chainC),
where the crystal contact made by Asp325 to the
neighbouring Lys230 is particularly weak (3.24 Å),
the orientation of Arg343 differs markedly from that
in chains A and B, and the bound ligand makes no
additional direct contacts with protein. The head
group of Arg343 is, however, aligned parallel with
the C5–C6′–O6′ group of man1 at a distance of 3.8 Å.
Glu333 OE2 interacts with Arg343 NH2 and NE in
chainA,with Arg343NH1 in chain B andArg343NE
in chain C.
The manα1–4man complex structure displays two
orientations of the terminal mannose. In the chain A
CRD, the terminal mannose displays the standard
orientation, similar to the manα1–2man and maltose
structures, with the Arg343 head group aligned
parallel with the mannose C5–C6′–O6′ group with
O6′making contacts of 3.34 Åwith Arg343 NH2 and
3.19 Å with Arg343 CZ. In chain C, the terminal
sugar is rotated by 180° with O3′ and O4′ inter-
changed relative to the standard orientation seen in
the manα1–2man structure (Fig. 4). The O4′ atom of
man1 thus interacts with Glu321 OE2 and Asn323
ND2, and the O3′ atom interacts with OE2 of Glu329
and ND2 of Asn341 (Table 1). There are contacts of
3.29 Å between O2′ and Arg343 NH1 and 3.22 Å
between O1′ and Asp325 OD2. In chain B, there is
evidence that both orientations of the terminal
mannose are present, although the alternative
orientation is much better defined in the electron
density, revealing contacts of 3.20 Å between O2′
and Arg343 NH1 and 3.39 Å between O1′ and
Asp325 OD2. The conformation of Arg343 itselfvaries between the subunits, with that in chain A
being less well defined and markedly different to
that in chains B and C. The interaction between
Glu333 OE2 and Arg343 NH1 is absent in chain A.
Galactose binding
The rfhSP-D-galactose structure crystals reveals
that galactose binds in a single orientation in the
CRD site via O1′ and O2′, which have a similar
equatorial configuration to the mannose-type O3′
and O4′ but with O1′ coordinated to Asn341 and
Glu329 and O2′ coordinated to Asn323 and Glu321
(see Fig. 3 and Table 1). The bound galactose, which
is very well defined in the electron density, is rotated
180° compared to the terminal glc sugar of maltose
so that the opposite sugar ring face is proximal to the
Arg343 side of the pocket. It is also rotated 180°
about the plane of the ring, resulting in an
orientation in the ligand-binding site, which spatial-
ly mimics the orientation of bound maltose. Al-
though C6′ is in a different position, O6′ in both
structures is in a very similar position. The bound
ligand interacts with Arg343 through a network of
contacts (2.92–3.24 Å) between galactose O5 and O6′
and Arg343 NH1 and NH2. These interactions are
similar in chains B and C (average, 3.02 Å), as is the
orientation of Arg343 and Asp325, but are consis-
tently longer in chain A (average, 3.19 Å) where the
conformation of Arg343 and Asp325 differs from
that in the other two chains. There are no direct
contacts between galactose and Asp325. There are
also interactions between O3′ and O4′ and water
molecules, and in chain A, O3′ interacts through a
water molecule with Gln281 OG1 in chain B of a
symmetry-related protein trimer.
Phospholipid-type binding
The overall features of the structure of the rfhSP-
D–inositol monophosphate complex are essentially
similar to those of the structure reported by Crouch
et al.,14 although the structure reported here has
been refined to significantly higher resolution and
with a more complete data set to that resolution
[99% complete to 1.75 Å, 65,000 independent
reflections here (see Table 3); 92% complete to
1.89 Å, 44,000 independent reflections in PDB file
2ork14]. In addition, the central calcium ion Ca4 is
absent in the earlier structure, resulting in asymme-
try in the Glu232–Lys246 interactions, with Glu232
in chain B repositioned to interact with the side
chain of the asymmetric tyrosine TyrC228.36 As
reported by Crouch et al.,14 the electron density
reveals bound IP in only two of the three CRDs with
IP being absent in chain A. Binding is the same in
CRD B and C, IP coordinating to the principal CRD
calcium via O4′ and O5′ in a similar manner to the
standard mannose-type binding through the adja-
cent equatorial hydroxyls O3′ and O4′ (see Table 1).
There is also an interaction between IP O6′ and NE
of Arg343 (2.93 Å in chain B, 3.20 Å in chain C) and,
via a water molecule, between O6′ and Asp325 OD2.
Table 3. Crystallographic data and refinement statistics for rfhSP-D ligand soaks
Galactose manα1–4man IP manα1–2man
Data collection
Wavelength (Å) 1.488 1.488 1.488 0.954
Temperature (K) 100 100 100 100
Space group P21 P21 P21 P21
Cell dimensions
a (Å) 55.74 55.52 55.45 56.08
b (Å) 108.58 108.45 107.72 108.78
c (Å) 55.88 55.82 55.67 55.91
β (°) 91.41 91.25 91.23 89.81
Maximal resolution (Å) 1.6 1.65 1.75 2.25
Highest-resolution bin (Å) 1.69–1.60 1.74–1.65 1.84–1.75 2.37–2.25
Observations 354,154 (23,390) 353,449 (36,056) 227,295 (24,386) 106,719 (9044)
Unique reflections 84,773 (8032) 74,691 (9255) 64,893 (7824) 31,502 (3256)
Completeness (%) 95.8 (84.6) 94.5 (87.7) 98.7 (94.3) 99.0 (97.4)
Rmerge
a 0.040 (0.119) 0.037 (0.151) 0.077 (0.194) 0.059 (0.222)
I/σ(I) 9.4 (4.4) 11.1 (4.3) 4.2 (3.3) 9.5 (1.6)
Refinement
Protein atomsb 3483 3476 3464 3336
Residues, chain A 204–355 204–355 205–355 210–355
Residues, chain B 204–355 205–355 204–355 210–355
Residues, chain C 204–355 204–355 206–355 211–355
Other atoms
Calcium ions 10 10 10 10
Ligand 36 36 32 36
Water 492 519 440 182
Resolution range (Å) 55.5–1.60 39.8–1.65 55.0–1.75 30.4–2.25
Rconv
c (%) 20.1 19.3 19.8 20.2
Rfree
d (%) 21.5 21.2 21.3 23.9
Average B-values (Å2)
Protein main chain 21.0 18.6 21.7 25.0
Ligand 23.2 27.1 31.0 38.0
Water 31.1 29.5 33.3 29.1
Ramachandran plot valuese (%)
Most favoured 92.6 93.5 94.1 92.4
Additional allowed 7.4 6.5 5.9 7.6
Disallowed 0.0 0.0 0.0 0.0
Figures in parentheses refer to the highest-resolution bin.
a Rmerge=∑h∑j∣Ih,j− Ih∣/∑h∑j∣Ih,j∣, where Ih,j is the jth observation of reflection h and Ih is the mean of the jmeasurements of reflection h.
b Excluding alternative side-chain conformations.
c Rconv=∑h∥Foh∣− ∣Fch∥/∑h∣Foh∣, where Foh and Fch are the observed and calculated structure factor amplitudes, respectively, for
reflection h.
d Rfree is equivalent to Rconv for a 5% subset of reflections not used in the refinement.
e Defined according to PROCHECK.
784 Ligand-Binding Determinants in hSP-DThe variation between chains B and C in the Asp325
and Asn323 crystal contacts is thus reflected in slight
variations in the IP orientation, which is, in turn,
accompanied by different orientations of Arg343
and different interactions between ligand and
Arg343. This difference is also evident in the
Glu333 OE2–Arg343 NH1 interaction, which is
weaker in chain C. The phosphate moiety is clearly
visible in the electron density map although the fine
detail of the oxygens is not clear. There are no close
contacts (b4 Å) between the phosphate moiety and
protein.Discussion
The additional calcium ion Ca4 located on the
trimeric axis at the neck–CRD interface, as first
observed in the rfhSP-D structure without bound
ligand,17 is present in all the ligand-bound structures
reported here and is always observed when calcium
sufficient to maintain a calcium concentration of2 mM or more within the crystal is included in the
cryobuffer.17 In the presence of Ca4, the three
interactions between Glu232 and Lys246 are sym-
metric, while in the absence of Ca4, GluB232 under-
goes a conformational change to interact with the
asymmetric tyrosine TyrC228 rather than LysB246.
This conformation of GluB232 was reported in the
maltose-bound structure, which has the central
calcium site depleted, and is present as a minor
conformation in the galactose structure here and in
the ligand-free calcium-bound structure.17
The structures are all consistent with all other
known hSP-D ligand-bound structures in that a
hydroxyl pair positioned similarly to mannose-type
O3′ and O4′ hydroxyls is required for binding, with,
for simple ligands, the bound sugar adopting an
orientation to enable this. The direct interactions
between protein and ligand at the primary ligand-
binding site Ca1 are, in virtually all reported
structures, restricted to the terminal sugar, with
minimal conformational change upon binding and
the topology of the CRD site held ready for the
785Ligand-Binding Determinants in hSP-Dligand.17 The exceptions are the previously reported
manα1–2man complex24 and simple maltoside and
maltotriose binding18 where interaction between the
third sugar ring and Phe335 is implicated.
While the opportunity for the second sugar man2
in chain A of the mannobiose structures to make a
crystal contact through a water molecule, as
observed in the maltose-bound structure,17 is
there, it is not taken. The orientation of man2 is
thus not constrained in any of the CRDs in either
structure, and as expected, there is no coherent
electron density that can be assigned to this
mannose. This contrasts with the manα1–2man
complex structure of Crouch et al.,24 in the same
crystal form as that described here, where the
second mannose in chain B, and only chain B, is
clearly defined.
While the ligand-binding residues are remarkably
conserved in the collectins (see Fig. 1), variability in
other binding determinants within the binding
pocket is evident throughout the family, including
the two residues that flank the entrance to the
pocket, Arg343 and Asp325 in hSP-D. A consider-
able body of work indicates that Arg343 plays a key
role in ligand selectivity, specificity, and
binding,14,17,23,24 but evidence of the influence of
Asp325 is relatively uncommon.17,25 In rat MBP, it
has been proposed that the bound sugar orientation
is determined by favourable long-range van der
Waals interaction with the residues equivalent to the
Asp325-Arg343 pair in human SP-D. These residues
are His189 and Ile207 in rat MBP-A and Val194 and
Val212 in rat MBP-C26–28 (see Fig. 1). The structures
reported here suggest that the medium- to long-
range weak interactions between the sugar and the
protein, involving primarily both Arg343 and
Asp325, determine the position and orientation of
the ligand and the relative positions of the O3′ and
O4′ equivalent hydroxyls and exert significant
influence on specificity. In a physiological setting,
it must be assumed that binding of the terminal
sugar coupled with the weak interactions is suffi-
cient to preferentially select one particular disposi-
tion of the ligand (as observed here in galactose,
manα1–2man, and IP), but that variation between
different ligands with the same terminal configura-
tion (e.g., manα1–4man and manα1–2man here) is
observed due to the linkage and nature of the non-
terminal carbohydrate units and their interactions
with the protein. In some cases (e.g., manα1–4man
here), multiple orientations of the same simple
ligand are observed, but while it may be possible
that selectivity fails to distinguish between the
different possibilities, it seems more probable that
the crystal environment itself is the determining
factor.
In all the known hSP-D structures, all based on the
same crystal form as first reported by Håkansson et
al.,36 the crystal contacts impinge directly but
variably on the binding site configuration in all
three CRDs. The resulting variable orientation of
Asp325 as determined by its interactions with
symmetry-related molecules, which differ for thethree chains, is clearly influential in determining the
variation in ligand orientation, particularly for
disaccharides and higher-order saccharides, and
hence, through the interactions of the bound sugar
with Arg343, the variable orientations of Arg343
itself. This is further evidenced by the structure
without bound ligand,17 where the conformation of
Arg343 is similar in all three chains. Thus, despite
the lack of close (b3.4 Å) interaction between the
ligand and Asp325 except in one chain of each of the
mannobiose structures, the interaction of the bound
ligand with Arg343 appears to be significantly
influenced by Asp325. However, although the
structural data clearly indicate that Asp325 is an
important ligand-binding determinant, the crystal
influence, which constrains the side chain in a non-
physiological orientation in each chain, precludes a
full interpretation of its role and leaves open to
question which orientation of terminal mannobiose,
and of other terminal disaccharides, may be present
in extended physiological ligands. Close contact of
Asp325 with bound ligand, for example, with
mannose O2′ in the standard mannose orientation
(see Fig. 4a–d), could be achieved through only
small torsional rotations of the Asp325 side chain.
This interaction is reported to be present in the
manα1–2man complex of Crouch et al.,24 calculated
distances being 3.35–4.05 Å across the three chains.
The freedom to orient the Asp325 side chain to
interact with incoming and bound ligand may result
in significantly different modes of ligand binding.
The adjacent glycine pair Gly326 and Gly327 (with
Gly326 also constrained by a crystal contact in chain
A) suggests significant flexibility in the position and
orientation of Asp325 in a physiological setting.
In the rfhSP-D IP structure, a symmetry-related
trimer in close proximity to the CRD site in the
subunit without bound ligand (chain A) may be
partially occupying, or preventing entry to, the IP
binding pocket, although maltose binding in the
equivalent site has been observed to utilise this
contact to bind the non-terminal glucose via a water
molecule.17 Placing IP in this chain in a similar
orientation as is observed in the other two CRDs
results in a clash between the phosphate and the
nearby symmetry-related rfhSP-D trimer. Although
the phosphate could rotate away to alleviate these
contacts, the defined phosphates in the IP bound to
chains B and C, in a similar conformation and free of
crystal contact restraints in both chains, suggest that
there is a particular preferred stereochemistry, not
achievable in chain A, of IP when bound to hSP-D.
This conformation, and the binding geometry itself,
would allow PI binding, with no steric hindrance
between protein and ligand, to be achieved by
superposition of the terminal IP on the bound IP
determined here. It has been suggested that the
positive charge associated with Arg343 may con-
tribute to the binding of hSP-D to negatively
charged ligands such as PI.23 More recent binding
studies14 show, however, that both the human SP-D
CRD and the R343A mutant bind poorly to PI as
compared with rat SP-D, which has lysine at
786 Ligand-Binding Determinants in hSP-Dposition 343. The human R343K mutant greatly
enhances PI binding while the reciprocal mutation
in the recombinant rat protein (K343R) decreases
binding. This suggests that in the human protein, PI
recognition depends largely on interactions with the
inositol moiety.14 Indeed, the structure reported
here shows that the phosphate group does not
interact with Arg343, which is proximal and
available, or with any other region of the protein,
providing further evidence of the dominance of
inositol recognition and a single, preferred IP
stereochemistry in the hSP-D/IP complex. While
there is no significant direct contact between bound
IP and Asp325, the variable crystal contacts result in
differing IP–Arg343 interactions in chains B and C
and differing Arg343 side-chain orientation, al-
though to a lesser extent than observed for the
mannobiose structures.
The influence of the variable crystal contacts
appears to be much reduced for the simple sugar
galactose as compared tomannobiose and, to a lesser
extent, IP, with the orientation of Arg343 and the
interactions between galactose and Arg343 being
similar in all three chains. While the structural results
suggest a relatively high affinity for galactose,
competitive ligand-binding studies13,37 show that
hSP-D has ligand specificity for glucose andmannose
type-ligands in preference to galactose. Presumably,
despite the network of interactions between O6′ and
O5′ and Arg343 NH1 and NH2, not present in any of
the other structures, the 180° reversal of the sugar ring
presents a much less favourable electronic configu-
ration to the binding pocket.
In the mannobiose structures, the terminal man-
nose displays the standard orientation in all three
CRDs of the manα1–2man complex but variable
orientation for manα1–4man (see Fig. 4). The
orientation in manα1–2man is similar to that
reported for the terminal α-glucose of maltose-
bound rfhSP-D17 and the maltotriose and p-nitro-
phenyl maltoside structures18 and for α-mannose of
both manα1-3man and an oligosaccharide com-
plexed with the rat MBP-A CRD.26,27 The reason
for the lack of definition of man2 in chain B of the
manα1–2man structure reported here, as opposed to
the clearly defined sugar in this chain in the previous
determination,24 is not clear, although this may be a
result of ligand molarity (10 mM final concentration
here, not known for the previous structure), resolu-
tion (2.25 Å here, 1.9 Å for the previous structure), or
the different buffers used for crystallisation. This
structural difference, as well as the variability of
ligand position and orientation within both struc-
tures, does, however, serve to reinforce the influence
of the variable crystal contacts throughAsp325, since
the contacts in chain B result in significant shifts in
bound ligand, and Arg343 oriented differently,
compared to the other two chains. This presumably
gives rise to the reported interaction of man2 with
Arg343 in, and only in, this chain of the previously
reported structure.24
One CRD of the manα1–4man bound structure
reported here also shows the standard orientation,while the other two CRDs show the terminal sugar
rotated by 180° as observed for mannose, glucos-
amine and fucose,28 and a series of disaccharides,26
bound to the rat MBP-C CRD. A mixture of terminal
sugar orientations, observed here in one CRD
(Chain B) of the manα1–4man complex, was also
observed in putative structures of manα1–2man and
manα1-6man soaked into trimeric MBP-A.26
This variation, across and within the two manno-
biose structures, of ligand orientation and its
medium- to long-range weak interactions with
protein reflect not only the varying crystal contacts
of Asp325, Gly326, Asp324, and Asn323 and their
influence, via bound ligand, on Arg343 (see Fig. 4)
but also the two different man–man linkages. Thus,
since the same crystal contacts are present in both
structures, and indeed in all the hSP-D structures
derived from this crystal form,14,17–19,24 the linkage
to the terminal sugar also appears to be a defining
factor in the position and orientation of bound
ligand. Nevertheless, the observed variation in
manα1–4man binding orientation suggests that
while a particular electronic configuration of the
terminal sugar ring may be preferred, it is not a
prerequisite for binding. This presumably provides
an increased ability to bind a wider range of
pathogens, although the strength of the interaction
may vary. Significantly, the structures do not allow
a definitive assignment of the preferred binding
mode of this ligand and perhaps of other ligands.
For more complex ligands with suitable double
hydroxyl patterns, the links between the bound
sugar residue and its neighbours may, as for a
terminal galactose in a physiologically relevant
ligand, preclude binding. Where accessible O3′
and O4′ equivalents are present in the ligand, it
seems likely that the importance of the favourable
weak interactions, particularly those involving
Asp325, Arg343, and the bound sugar, will be
maintained with flexibility in ligand orientation if
the overall ligand topology is such that the preferred
binding mode cannot be achieved spatially. Despite
this flexibility, affinity may be greatly reduced or
abolished if there are sterically limited opportunities
for overall and/or internal orientational rearrange-
ment of ligand. In addition, while the combined
structural evidence shows clearly that Asp325 is a
major ligand-binding determinant, there is as yet no
structural data that reveal the orientation and
position of this key residue, or, as a result, bound
ligand, in a physiologically relevant setting. The
influence of the crystal thus hinders definitive
assignment of preferred binding modes, suggesting
that caution should be exercised in attempts to
describe the binding of extended natural ligands
based on the structurally characterised ligand-
binding modes of a subset of their terminal
carbohydrate substituents. Indeed, this structural
feature may offer an explanation for the failure
of current rfhSP-D crystals to bind ligands such
as N-acetyl muramic acid, GalNAc-4-sulfate, and
bacterial and host-genome nucleic acids and their
components, which have been identified as ligands
787Ligand-Binding Determinants in hSP-Dby BIAcore chip binding studies based on compe-
tition with the SP-D–mannan interaction.3,4,9,10Materials and Methods
Crystallisation and data collection
The expression and purification of the recombinant
homotrimeric fragment of hSP-D (rfhSP-D), consisting of
the 177 C-terminal residues (Gly179 to Phe355), have been
described previously.30,34 Native crystals of rfhSP-D were
grown in sitting drops consisting of an equal volume (2 μl)
of protein solution (7.5 mg ml−1 protein in 10 mM Tris,
140 mM NaCl, and 10 mM CaCl2, pH 7.4) and precipitant
buffer (15.75–16.5% polyethylene glycol 4000 in 100 mM
Tris, pH 8.0) as described previously.17 IP, galactose,
manα1–2man, and manα1–4man were purchased from
Sigma. Crystals were soaked with ligand and prepared for
cryocooling by addition of ligand and 10 mMCaCl2 to 2,4-
methylpentane diol (MPD) cryobuffers prepared using
MPD in precipitant buffer. Successive addition of 2 μl
aliquots of increasing concentrations (5, 10, 15, and 20%) of
MPD cryobuffer to the well was carried out, followed by
addition of a further 2 μl aliquot of 20% MPD cryobuffer
and an exchange of the resulting buffer with 20% MPD
cryobuffer. The final concentrations of ligand in the
cryobuffers were as follows: 10 mM IP, 100 mM galactose,
6 mM manα1–4man, and 10 mM manα1–2man. The IP,
galactose, and manα1–4man data were collected on an
ADSC Quantum 4R CCD detector on Daresbury SRS
station 14.1. Low-resolution (3.0 Å, 125 images, 1.5°
oscillation) and high-resolution (200 images, 1.0° oscilla-
tion) data sets were collected for galactose and manα1–
4man ligands. The manα1–2man data were collected on
the microfocus beamline ID13 at the European Synchro-
tron Radiation Facility. The crystal was of maximum
dimension 50 μm, and data were collected in three
segments with successive translations to a fresh part of
the crystal for each data segment. Integrated intensities
were calculated with the program MOSFLM.38 Data
collection and processing statistics are given in Table 3.
Structure solution and refinement
Isomorphism was sufficient to allow the coordinates of
the previously determined 1.6-Å rfhSP-D structure17 to be
used as a starting model for the ligand-bound rfhSP-D
structures. The structures were refined using the pro-
grams X-PLOR39 (initially) and CNS.40 Maps were
calculated using CNS and the CCP4 program suite,41
including density modification (solvent flattening and
histogram matching, but not NCS averaging), and
models were built using the graphics program O.42
Topology and parameter files for ligand were obtained
from the HIC-Up server.43 Refinement statistics are given
in Table 3. All main- and side-chain stereochemical
parameters either fall inside or are better than those
expected (PROCHECK44) with no residues in generously
allowed or disallowed regions. Molecular figures were
generated using MOLSCRIPT.45
Accession numbers
The coordinates and structure factors for manα1–2man
(3IKQ), manα1–4man (3IKR), galactose (3IKN), and IP
(3IKP)-bound rfhSP-D have been deposited with the PDB.Acknowledgements
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